Pituitary & hypothalamus

Importance of Intraoperative Factors in Postoperative Arginine Vasopressin Deficiency After Pituitary Adenoma Surgery

Endocr PractPublished Retrospective cohort study

Authors' conclusion

The reported incidence of AVP-D has a considerably wide range. A consistent definition and grading for AVP-D will increase consistency and comparability among studies. Nonetheless, most patients experience AVP-D on a temporary basis, and only a few require long-term treatment. Cerebrospinal fluid leak, gross total resection, and hormonal remission were identified as risk factors for postoperative AVP-D. We believe that the intraoperative risk factors play the main role in postoperative AVP-D. The course of surgery and operative findings help us plan selective postoperative patient monitoring and care.

Study context

Population
Patients who underwent endoscopic transsphenoidal surgery for pituitary adenomas
Participants
520 patients
Outcome
Incidence of postoperative AVP-D (early, transient, permanent) and associated risk factors

Main finding

As reported in the abstract

Postoperative AVP-D incidence

Early arginine vasopressin deficiency (AVP-D)

24.8%

Transient AVP-D

1.9%

n = 10

Permanent AVP-D

1.1%

6 patients

Observational data: associations, not effects.

Further findings

Risk factors associated with higher incidence of AVP-D

Gross total resection
P = 0.027
Hormonal remission
P = 0.002
Pituitary stalk manipulation
P < 0.001
Intraoperative cerebrospinal fluid leak
P < 0.001
AVP-D not related to tumor size
All patients with permanent AVP-D had somatotroph adenomas

LOS

LOS prolonged by AVP-D on average (days)
1.5 (P = .018)

Original publication

Importance of Intraoperative Factors in Postoperative Arginine Vasopressin Deficiency After Pituitary Adenoma Surgery. Endocr Pract. Published 11 December 2023. doi:10.1016/j.eprac.2023.12.003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.